The opposite change was shown for myosin-binding protein C (cMyBPC), which was significantly reduced in MetS-VLDL-injected mice (msVLDL in Figure 4d) atrial tissues but not in HL-1 cells after MetS-VLDL treatment. Here, MYBPC3 is linked to metabolic syndrome.